Halozyme Therapeutics
HALO
#2003
Rank
โ‚ฌ7.19 B
Marketcap
56,82ย โ‚ฌ
Share price
1.06%
Change (1 day)
54.62%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚ฌ1.77 B

According to Halozyme Therapeutics's latest financial reports the company's total assets are โ‚ฌ1.77 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ1.56 B-8.67%
2022-12-31โ‚ฌ1.71 B76.84%
2021-12-31โ‚ฌ0.97 B104.62%
2020-12-31โ‚ฌ0.47 B-5.86%
2019-12-31โ‚ฌ0.50 B31.14%
2018-12-31โ‚ฌ0.38 B-11.31%
2017-12-31โ‚ฌ0.43 B74.3%
2016-12-31โ‚ฌ0.24 B49.31%
2015-12-31โ‚ฌ0.16 B22.13%
2014-12-31โ‚ฌ0.13 B85.05%
2013-12-31โ‚ฌ73.68 M-27.72%
2012-12-31โ‚ฌ0.10 B101.31%
2011-12-31โ‚ฌ50.63 M-26.45%
2010-12-31โ‚ฌ68.84 M27.76%
2009-12-31โ‚ฌ53.88 M-0.7%
2008-12-31โ‚ฌ54.26 M-22.67%
2007-12-31โ‚ฌ70.17 M100.9%
2006-12-31โ‚ฌ34.93 M101.75%
2005-12-31โ‚ฌ17.31 M59.58%
2004-12-31โ‚ฌ10.84 M1993.9%
2003-12-31โ‚ฌ0.51 M134.91%
2002-12-31โ‚ฌ0.22 M645.6%
2001-12-31โ‚ฌ0.02 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ0.40 B-77.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ64.85 B 3,549.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ23.74 B 1,236.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ195.09 B 10,877.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ125.51 B 6,962.63%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ163.41 B 9,094.85%๐Ÿ‡บ๐Ÿ‡ธ USA